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a b s t r a c t
Hepatosplenomegalyamongschool-agedchildren in sub-SaharanAfrica ishighlyprevalent.
Twoof themore commonaetiological agents of hepatosplenomegaly, namely chronic expo-
sure tomalaria and Schistosomamansoni infection, can result in similar clinical presentation,
with the liver and spleen being chronically enlarged and of a ﬁrm consistency. Where co-
endemic, the two parasites are thought to synergistically exacerbate hepatosplenomegaly.
Here, two potential health consequences, i.e. dilation of the portal vein (indicative of
increased portal pressure) and stunting of growth, were investigated in a study area where
children were chronically exposed to malaria throughout while S. mansoni transmission
was geographically restricted. Hepatosplenomegaly was associated with increased portal
vein diameters, with enlargement of the spleen rather than the liver being more closely
associatedwith dilation. Dilation of the portal veinwas exacerbated by S. mansoni infection
in an intensity-dependent manner. The prevalence of growth stunting was not associated
with either relative exposure rates to malarial infection or with S. mansoni infection sta-
tus but was signiﬁcantly associated with hepatosplenomegaly. Children who presented
with hepatosplenomegaly had the lowest height-for-age Z-scores. This study shows that
hepatosplenomegaly associated with chronic exposure to malaria and schistosomiasis is
not a benign symptom amongst school-aged children but has potential long-term health
consequences.
Society© 2009 Royal∗ Corresponding author. Tel.: +44 1223 333 332; fax: +44 1223 333 346.
E-mail address: sw320@cam.ac.uk (S. Wilson).
0035-9203/$ – see front matter © 2009 Royal Society of Tropical Medicine and H
doi:10.1016/j.trstmh.2009.08.006of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All
rights reserved.
1. IntroductionIn endemic areas, school-aged children bear the great-
est burden of infection with Schistosoma mansoni and this
is associated with subtle morbidities that are distinct from
the severe manifestations of hepatic periportal ﬁbrosis,
for which the peak prevalence occurs in much older age
ygiene. Published by Elsevier Ltd. All rights reserved.
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roups than the peak in S. mansoni infection intensities.1
lthough many of these subtle morbidities and their con-
equences are difﬁcult to assess or attribute to a single
ausative agent, they are thought to be major contribu-
ors to the disability-adjusted life-years associated with S.
ansoni infections.2 One manifestation of the high infec-
ion intensities carried by school-aged children is chronic
epatosplenomegaly in which these organs have a ﬁrm to
ard consistency when palpated, often being extensively
nlarged beyond the costal line,3,4 but not associated with
ltrasound-detectable hepatic ﬁbrosis.5,6
Chronic exposure tomalaria can also cause overlapping
hysical signs of hepatosplenomegaly of a ﬁrm consistency
n school-aged children,7,8 which contributes to what has
een described as an epidemic of hepatosplenomegaly in
hildren throughout the tropics.9 Plasmodium-associated
epatosplenomegaly has been reported as a confounder
f S. mansoni-associated hepatosplenomegaly,3,10 how-
ver there is evidence that chronic exposure to malaria
nd infection with schistosomiasis may interact in child-
ood hepatosplenomegaly.11,12 Studies in Kenya have
hown that, as well as being associated with higher
. mansoni infection intensities,6,13 S. mansoni-associated
epatosplenomegaly ismore severe in areaswheremalaria
s a greater public health problem, although it is not
ssociated with concurrently detectable parasitaemia.13
igh levels of IgG3 against P. falciparum schizont anti-
en (Pfs-IgG3), a marker of relative exposure to malaria
nd therefore frequency of infection,14 are also associated
ith hepatosplenomegaly.12,15,16 Thus, in sub-Saharan
frica hepatosplenomegaly is common amongst school-
ged children who are yet to develop immunity to
nfection with Plasmodium spp. or S. mansoni, and where
xposure to the two infections overlaps geographically
epatosplenomegaly is both more prevalent13 and more
evere.12,16
The adverse effects of this hepatosplenomegaly are not
ell studied, although it is most prevalent during a critical
ge in terms of human growth and intellectual develop-
ent.
Herewepresent data fromaKenyan school-aged cohort
n which hepatosplenomegaly was (a) highly prevalent
ven in the absence of detectable S. mansoni infection,
b) associated with Pfs-IgG3 levels and (c) clearly exacer-
ated in children who were infected with S. mansoni.16
his allowed us to test whether or not childhood hep-
tosplenomegaly, in the presence or absence of detectable
. mansoni infection, was associated with dilated portal
eins and/or stunting of growth. A school feeding pro-
ramme, introduced in 1999, ensured that the study was
ot confounded by current poor protein andmicronutrient
ntake.
. Materials and methods.1. Study area and population
The study area in Makueni District, Kenya, in which S.
ansoni transmission was restricted to the east owing to
abitat availability for the Biomphalaria snail intermediateical Medicine and Hygiene 104 (2010) 110–116 111
host but where P. falciparum was transmitted throughout,
aswell as the selectionof school-agedchildren (4–17years)
from two primary schools who participated in the study
are described in detail elsewhere.16 Informed consent was
obtained from parents or guardians. Five stool samples
were collected from participating children and two 50mg
Kato–Katz slides17 were prepared from each stool sample.
A child was considered free of S. mansoni infection if all
10 slides were negative for S. mansoni eggs. All S. mansoni
infections were treated with a single dose of praziquan-
tel 40mg/kg body weight. Pfs-IgG3 levels were measured
by ELISA as described previously.14 Malaria transmission is
considered tobemesoendemicdue tohighly seasonal rains,
with prevalence amongst schoolchildren of microscopy-
detectable P. falciparum infections being recorded as 15.3%
at the end of the long dry season, rising to 51.8% during the
high transmission season.14 At the time of the study, the
prevalence of microscopy-detectable P. falciparum infec-
tions was 21.0% at one primary school and 19.6% at the
other and was not associated with hepatosplenomegaly.16
The ﬁeld work was carried out in May–June 2002.
2.2. Clinical examination
Children were examined clinically for palpable,
enlarged livers and spleens of a ﬁrm consistency and
were classed into groupings of (a) no organomegaly, (b)
splenomegaly only, (c) hepatomegaly only and (d) hep-
atosplenomegaly, as described previously.16 This variable
is referred to as ‘clinical group’. Clinical measurements
of the left liver lobe and spleen were also classed as an
ordinal variable for extent of organomegaly. The ﬁrst
category was no enlargement of the organ. The left liver
lobe was considered moderately enlarged if palpable
3–5 cm and substantially enlarged if palpable >5 cm below
the costal margin in the liver mid-sternal line. The spleen
was considered moderately enlarged if palpable 3–4 cm
below the costal margin in either the mid-clavicular or
mid-axillary line or substantially enlarged if palpable
>4 cm below the costal margin in either line.
2.3. Ultrasound examination
A randomised cohort of 272 children aged 4–17 years
was selected from two primary schools in the area, Yum-
buni Primary to thewest andMatangini Primary to the east,
to participate in ultrasound examinations. The children
were examined using an Aloka SSD-500 portable ultra-
sound machine with a 3.5MHz curvilinear (60%) probe
(Imai, Tokyo, Japan). Ultrasound examinations were con-
ducted according to the Niamey protocol18 and included
measurements of the portal vein diameter (PVD), taken
in the right oblique view, at the point of entrance into
the porta hepatis at the ventral lower end of the caudate
lobe; themeasurement takenwas thedistancebetween the
inner sides of the walls. Ultrasound measurements of PVD
requiredheight standardisationprior toanalysis.Asnodata
are available from a suitable reference population, stan-
dardisation was carried out internally by linear regression.
The appearance of the liver parenchyma was assessed in
the substernal transverseandsubcostal transhepatic views,
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and liver scores were used to assign ﬁbrosis scores to the
appearance observed. Score ‘C’ and above on a scale of A to
F are considered indicative of periportal ﬁbrosis. The pres-
ence of portosystemic collaterals and ascites was recorded
if found.
2.4. Anthropometric examination
Heights were measured to the nearest eighth of an inch
and converted into centimetres. Weight was measured
to the nearest half kilogram. Trained local demographers
interviewedadult familymembers to determine the year of
birth of participating schoolchildren. The mid-point of the
year was assigned as the month of birth for calculation of
Z-scores. To compare anthropometric measurements with
international standards, height-for-age Z-scores (HAZ) and
body mass index (BMI)-for-age Z-scores (BMIZ) were cal-
culatedusing theCDC2000 standards andNutStat software
(http://www.cdc.gov/epiinfo/).
2.5. Statistical analysis
Complete parasitological, serological, clinical and
anthropometric data were available for 353 children.
Wasting and stunting were assigned using the respec-
tive WHO-deﬁned cut-offs of BMIZ<–2 and HAZ <–2.
Proportions were compared using Pearson’s 2 analysis
and continuous variables were compared by Student’s t-
test and ANOVA with Hochberg GT2 post-hoc analysis.
Pearson’s correlation coefﬁcients were calculated, except
in relation to S. mansoni infection intensities when non-
parametric Spearman’s rank correlation coefﬁcients were
calculated. Logistic regression models were constructed
using presence or absence of stunting as the dependent
variable. Analysis of co-variance (ANCOVA) models were
constructed using HAZ as the continuous dependent vari-
able.
3. Results
3.1. Ultrasound image patterns and portal vein diameter
measurements
No S. mansoni eggs were detectable in the stool samples
provided by 158 of the children examined by ultrasound.
Amongst the 114 childrenwho did have detectable S. man-
soni eggs, the infection intensity ranged from 2 eggs per
gram of faeces (EPG) to 713 EPG, with a median infec-
tion intensity of 35.42 EPG. No hepatic periportal ﬁbrosis
was detected during the ultrasound examinations in either
group,with87.3%of childrenwithout detectable S.mansoni
infections and 71.9% of children with detectable S. man-
soni infections having pattern A scans; all other children
had pattern B scans. Neither ascites nor collateral veins
were detected during either the clinical or the ultrasound
examinations.There was no signiﬁcant difference in the prevalence
of organomegaly between children with and without
detectable S. mansoni eggs (2 =1.492, P=0.684). How-
ever, height-adjusted PVD measurements were found to
be greater in children who had detectable S. mansoni eggsFigure 1. Portal vein diameters (PVD) by Schistosoma mansoni infection
status. Shown are the mean±2 standard errors of the height-adjusted
PVDs for children with and without S. mansoni infection.
than in those who did not (t=–3.165, P=0.002) (Figure 1).
Height-adjusted PVDs of children with detectable S. man-
soni eggs were positively correlated with S. mansoni
infection intensities (=0.261, P=0.005). Pfs-IgG3 lev-
els were signiﬁcantly correlated with height-adjusted
PVD measurements both in S. mansoni egg-negative and
egg-positive children (r=0.214, P=0.008; and r=0.211,
P=0.040, respectively).
Children without detectable S. mansoni eggs but with
hepatosplenomegaly had signiﬁcantly greater height-
adjusted PVDs than S. mansoni egg-negative children with
enlargement of the liver only (F=4.622, P=0.004; post-
hoc, P=0.010). Post-hoc analysis indicated that children
withhepatosplenomegaly alsohadgreaterheight-adjusted
PVDs than children with enlargement of neither organ,
but this failed to reach signiﬁcance (P=0.067). No signiﬁ-
cant relationship was seen between height-adjusted PVD
measurements and clinical groupings of organomegaly
(F=2.015, P=0.117) in S. mansoni egg-positive children.
Amongst S.mansoniegg-negativeandegg-positive children
therewas no signiﬁcant difference in height-adjusted PVDs
between children who had no, moderate or substantial
enlargement of the left liver lobe (F=1.566, P=0.212; and
F=2.84, P=0.063, respectively). However, height-adjusted
PVDs did differ signiﬁcantly between children with no,
moderate and substantial enlargement of the spleen. Post-
hoc analysis indicated that height-adjusted PVDs were
greater for children with substantially enlarged spleens
comparedwith childrenwith no enlargement of the spleen
(S. mansoni egg-negative, F=7.852, P=0.001; S. mansoni
egg-positive, F=3.797, P=0.025) (Figure 2).
3.2. AnthropometryOf the childrenparticipating in the study, 56.4% (n=199)
were stunted according to international standards. Poor
BMI was not as prevalent as stunting, with 25.2% (n=89)
of the children examined found to be wasted according to
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Figure 2. Portal vein diameters (PVD) by Schistosoma mansoni infection
status and extent of splenomegaly. Shown are the mean±2 standard
errors of the height-adjusted PVDs for children with differing extents of
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Figure 3. Proportion of children who were stunted, by Schistosoma man-
soni infection status and clinical groupings of organomegaly. Shown areplenomegaly. Results are shown separately for children with and with-
ut S. mansoni infection., Spleen palpable 0–2 cm below the costal line;
, spleen palpable 3–4 cm below the costal line; and , spleen palpable
4 cm below the costal line.
nternational standards. None of the parasitological or clin-
cal variableswere signiﬁcantly associatedwith BMIZ (data
ot shown). A higher proportion of children with S. man-
oni infections were stunted compared with those who did
ot have detectable S. mansoni infections [61.7% (79/128)
s. 53.3% (120/225)], but this did not reach signiﬁcance
2 =2.333, P=0.127). Schistosoma mansoni egg-negative
hildren who were stunted had higher Pfs-IgG3 levels
t=–3.647, P<0.001) than those who were not stunted.
similar trend was observed for children who were S.
ansoni egg-positive, but this failed to reach signiﬁcance
t=–1.368, P=0.174).
Both for S. mansoni egg-negative and egg-positive chil-
ren there was a signiﬁcant association between being
tuntedandclinical groupingsof organomegaly (2 =9.160,
= 0.027; and 2 =10.401, P=0.015, respectively). Those
resentingwith hepatosplenomegaly had the highest rates
f stunting (Figure 3). A logistic regressionmodel was con-
tructed to control for age and sex (Table 1) and it was
ound that boys were more likely to be stunted than girls
nd that the prevalence of stunting increased with age.
able 1
ogistic regression analysis of stunting of growth
Variable P-value Odds ratio (95% CI)
Sex <0.001 2.734 (1.691–4.421)
Age <0.001 1.234 (1.148–1.373)
Schistosoma mansoni 0.678
Pfs-IgG3 0.113
Group: 0.001
Splenomegaly only 0.15 0.472 (0.169–1.314)
Hepatomegaly only 0.109 2.011 (0.859–4.709)
Hepatosplenomegaly 0.061 2.264 (0.963–5.322)
fs: Plasmodium falciparum schizont antigen.
odel ﬁt: 2 = 76.612, P < 0.001; Nagelkerke pseudo-R2 = 0.262.the proportion of children who were stunted according to international
classiﬁcation (height-for-age Z-score <2) in each of the clinical groups.
Results are shown separately for children with and without S. mansoni
infection.
After controlling for age and sex as well as relative expo-
sure tomalaria andschistosomiasis infectionstatus, clinical
group remained a signiﬁcant predictor of stunting. Param-
eter estimates failed to indicate in which clinical groups
the prevalence of stunting was signiﬁcantly increased.
However, the prevalence of stunting amongst children
with hepatosplenomegaly compared with children with-
out organomegaly was of borderline signiﬁcance.
To examine the association between clinical group and
stunting further, ANCOVA was carried out using HAZ as
the dependent variable. The model was controlled for age
(F=83.077, P<0.001) and sex (F=7.333, P=0.007), and clin-
ical group was added as a ﬁxed factor (F=5.341, P=0.001).
Pairwise comparisons between groups, adjusted for mul-
tiple comparisons, are shown in Table 2. Children with
hepatomegaly only and those with hepatosplenomegaly
had signiﬁcantly lower HAZ scores than children with
splenomegaly only. There was a borderline signiﬁcance
in lower HAZ for children with hepatosplenomegaly com-
pared with children with no organomegaly.
4. Discussion
Although there are many known aetiological agents
of hepatosplenomegaly in school-aged children, two of
the most common are S. mansoni infection and chronic
exposure to malaria. Two potential consequences of hep-
atosplenomegaly in school-aged children, namely dilation
of thehepatic vascular system (which could be indicative of
increases in portal pressure) and stunting of growth, were
investigated in this paper.
In a previous study of children presenting with hep-
atosplenomegaly without ultrasound-detectable ﬁbrosis,
28% were found to be classiﬁable as having portal
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Table 2
Pairwise comparisons of height-for-age Z-scores between children in different clinical groupsa
Clinical group Mean difference (95% CI) P-value
No organomegaly vs. splenomegaly −0.161 (−0.873, 0.551) 0.992
hepatomegaly 0.480 (−0.131, 1.091) 0.209
hepatosplenomegaly 0.558 (−0.001, 1.124) 0.056
Splenomegaly vs. hepatomegaly 0.641 (0.036, 1.246) 0.032
hepatosplenomegaly 0.791 (0.160, 1.278) 0.004
trollingHepatomegaly vs. hepatosplenomegaly
a Pairwise comparisons between clinical groupings are shown after con
comparisons.
hypertension under the current Niamey protocol.6 How-
ever, the hepatosplenomegaly that these children pre-
sented with was also associated with Pfs-IgG3 levels,12
a marker of chronic exposure to malaria.14 Early histo-
logical studies on biopsy specimens from children with
malaria-associated hepatomegaly indicate that this may
also be accompanied by dilation of the liver’s vascular
system.9 Ultrasound PVD measurements, taken to assess
S. mansoni-associated pathology, could therefore be con-
founded by chronic exposure to Plasmodium infections.
In the present study, amongst the children who did not
have detectable S. mansoni infections, the height-adjusted
PVDs were greatest in those children who presented
with hepatosplenomegaly, indicating that the presence
of organomegaly in the absence of detectable S. man-
soni infection was associated with dilation of this vein.
However, analysis of the height-adjusted PVD measure-
ments of children with different extents of hepatomegaly
or splenomegaly suggests that enlargement of the spleen,
rather than enlargement of the liver, was the major
contributor to dilation of the portal vein. The height-
adjusted PVDs were also signiﬁcantly related to Pfs-IgG3
levels. Whether dilation of the portal vein was due to
P. falciparum-associated enlargement of the liver or was
due to downstream consequences of increased demand
for blood by the enlarged spleen cannot be determined
from the present study. However, this study does indi-
cate that in areas where there is mesoendemic seasonal
transmission of malaria, resulting in a high prevalence of
hepatosplenomegaly in school-age children, dilation of the
portal vein can occur.
Detectable S. mansoni infection was found to exacer-
bate dilation of the portal vein. The exacerbation of portal
vein dilation was S. mansoni infection intensity dependent,
concurring with a previously reported study involving a
morbidity-only cohort of Akamba children, selected on the
basis of having hepatomegaly,6 as well as a cross-sectional
study of Egyptian children.19 During earlier surveys, some
S.mansoni-infected children fromMachakos, nowMakueni
District, Kenya,were found tohave the severe complication
of portal hypertension and had to be hospitalised,13 and
upon admission a subset were found to have oesophageal
varices in the absence of periportal ﬁbrosis. However, the
ultrasound examination was part of the overall clinical
examination and did not follow the current standardised
protocols (E. Ireri, unpublished observations). The study
by Vennervald et al.6 and the present study have both
applied the standardised Niamey protocol for ultrasound
examination18 and the implication from these studies is0.078 (−0.327, 0.482) 0.997
for age and sex by analysis of co-variance and adjusting for multiple
that even when ultrasound-detectable periportal ﬁbro-
sis is absent, increases in portal pressure related to S.
mansoni intensity may occur. Further assessment using
techniques such asDoppler ultrasound,whichwould allow
determination of blood ﬂow rate and direction, should be
implemented to conﬁrm whether the exacerbation of por-
tal vein dilation by S. mansoni infection is due to increases
in portal pressure.
Unlike dilation of the portal vein, the prevalence of
stunting was not found to be signiﬁcantly increased by
the presence of S. mansoni infection, and the signiﬁcantly
higher levels of Pfs-IgG3, a marker of age and geographical
exposure to Plasmodium infections, amongst children who
were stunted was no longer apparent after controlling for
age and sex. However, children with hepatosplenomegaly
did have the highest prevalence of stunting in compari-
son with children who were assigned to the other clinical
groups, andHAZ scoreswere signiﬁcantly lower in children
withhepatosplenomegaly andhepatomegaly after control-
ling for sex and age. Older children were more likely to be
stunted than younger children. Although the use of cross-
sectional data can bemisinterpreted due to environmental
factors during early life causing long-lasting effects on
HAZ,20 poor growth increments have been reported during
the later stages of childhood and adolescence,21 indicat-
ing that deﬁcits in growth continue to occur amongst this
age group. The increase in degree of stunting that occurs
with age amongst children with hepatosplenomegaly is
in concurrence with a previous study in which internally
standardised height-for-age decreased with age amongst
Akamba children with hepatomegaly.22 Boys were found
to be more stunted than girls. In concurrence with this,
a meta-analysis of studies, albeit of younger children, has
shown that in sub-Saharan Africa boys have higher rates of
stunting than girls.23
Between-household variation in social and economic
factors, which will impact both on nutritional intake in the
children’s diet and their exposure to infectious diseases,
were not controlled for and are confounders that cannot
be ruled out. A Brazilian study has shown that S. mansoni-
infected children presenting with palpable spleens still
have poorer height-for-age after controlling for socioeco-
nomic factors.24 However, direct extrapolation from this
Brazilian study in a non-malarial region is not possible,
as presentation with S. mansoni-associated splenomegaly
in areas of non- or low-endemicity for Plasmodium spp. is
likely to be indicative of an alternative underlying mecha-
nism of splenomegaly to that present in the current study
where malaria is mesoendemic. Current levels of wasting
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ere at a relatively low level in comparison with stunting,
hich may be attributable in part to the introduction of
he school feeding programme that ensures good levels of
icronutrient and protein intake.
It has been proposed that chronic inﬂammation, and
n particular production of TNF and IL-6, may have a
irect impact on the linear growth of children by affecting
one remodelling.25 An inﬂammatory response localised
ithin the liver could also inhibit linear growth, as the
nﬂammatory cytokine TNF can reduce the production
f insulin growth factor-1 (IGF-1), a hormone involved in
inear growth, by the liver.26 Thus, this is a potential mech-
nism for the strong association between hepatomegaly
nd stunted growth thatwas observed, particularly as hep-
tosplenomegaly within Akamba children has been found
o be associated with a pro-inﬂammatory Th1 response27
nd low levels of regulatory cytokines.28 Low levels of IGF-
have been shown to be associated with the presence
f hepatosplenic schistosomiasis, indicative of periportal
brosis, in Brazil.29 However, it remains to be determined
hether or not there is an association between IGF-1 lev-
ls and childhood hepatosplenomegaly in the absence of
eriportal ﬁbrosis.
In conclusion, this study has shown that children with
epatosplenomegaly had both greater dilation of their
ortal veins, which could be indicative of increases in
ortal pressure, and higher rates of stunting of growth.
oth consequences were apparent in S. mansoni egg-
egative children with hepatosplenomegaly, highlighting
he largely ignored public health implications of long-term
xposure to Plasmodium infections, and therefore recur-
ent infections with Plasmodium, suffered by school-aged
hildren. Children who were infected with S. mansoni and
hronically exposed to malarial infections, a group who
ave exacerbation of hepatosplenomegaly, had greater
ilation of the portal vein, which was dependent both on
. mansoni infection intensity and the extent of spleen
nlargement. This indicates that where exposure to both
arasites is occurring, the health consequences as well
s the underlying hepatosplenomegaly are exacerbated.
ence, the study shows that persistent ﬁrm-to-hard hep-
tosplenomegaly associated with chronic exposure to
alaria and S. mansoni infection is not a benign symptom
mongst school-aged children but has potential long-term
ealth consequences.
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